vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.
Mama's Creations, Inc. is the larger business by last-quarter revenue ($47.3M vs $44.9M, roughly 1.1× AbCellera Biologics Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -19.9%, a 21.1% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 50.0%). Mama's Creations, Inc. produced more free cash flow last quarter ($3.7M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 33.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
ABCL vs MAMA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $47.3M |
| Net Profit | $-8.9M | $540.0K |
| Gross Margin | — | 23.6% |
| Operating Margin | -63.7% | 1.7% |
| Net Margin | -19.9% | 1.1% |
| Revenue YoY | 788.4% | 50.0% |
| Net Profit YoY | 73.9% | 31.7% |
| EPS (diluted) | $-0.03 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $47.3M | ||
| Q3 25 | $9.0M | $35.2M | ||
| Q2 25 | $17.1M | $35.3M | ||
| Q1 25 | $4.2M | $33.6M | ||
| Q4 24 | $5.0M | $31.5M | ||
| Q3 24 | $6.5M | $28.4M | ||
| Q2 24 | $7.3M | $29.8M | ||
| Q1 24 | $10.0M | $26.7M |
| Q4 25 | $-8.9M | $540.0K | ||
| Q3 25 | $-57.1M | $1.3M | ||
| Q2 25 | $-34.7M | $1.2M | ||
| Q1 25 | $-45.6M | $1.6M | ||
| Q4 24 | — | $410.0K | ||
| Q3 24 | $-51.1M | $1.1M | ||
| Q2 24 | $-36.9M | $553.0K | ||
| Q1 24 | $-40.6M | $1.4M |
| Q4 25 | — | 23.6% | ||
| Q3 25 | — | 24.9% | ||
| Q2 25 | — | 26.1% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 24.2% | ||
| Q2 24 | — | 25.0% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | -63.7% | 1.7% | ||
| Q3 25 | -851.8% | 4.8% | ||
| Q2 25 | -290.2% | 4.5% | ||
| Q1 25 | -1479.6% | 5.7% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | -1439.4% | 5.7% | ||
| Q2 24 | -1276.2% | 2.6% | ||
| Q1 24 | -551.5% | 7.4% |
| Q4 25 | -19.9% | 1.1% | ||
| Q3 25 | -637.8% | 3.6% | ||
| Q2 25 | -203.3% | 3.5% | ||
| Q1 25 | -1077.2% | 4.8% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | -785.4% | 4.0% | ||
| Q2 24 | -504.3% | 1.9% | ||
| Q1 24 | -408.0% | 5.3% |
| Q4 25 | $-0.03 | $0.01 | ||
| Q3 25 | $-0.19 | $0.03 | ||
| Q2 25 | $-0.12 | $0.03 | ||
| Q1 25 | $-0.15 | $0.04 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-0.17 | $0.03 | ||
| Q2 24 | $-0.13 | $0.01 | ||
| Q1 24 | $-0.14 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $18.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $49.6M |
| Total Assets | $1.4B | $84.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $18.1M | ||
| Q3 25 | $83.2M | $9.4M | ||
| Q2 25 | $92.4M | $12.0M | ||
| Q1 25 | $159.3M | $7.2M | ||
| Q4 24 | $156.3M | $9.3M | ||
| Q3 24 | $126.6M | $7.4M | ||
| Q2 24 | $148.3M | $13.0M | ||
| Q1 24 | $123.6M | $11.0M |
| Q4 25 | $966.9M | $49.6M | ||
| Q3 25 | $964.0M | $29.6M | ||
| Q2 25 | $1.0B | $26.4M | ||
| Q1 25 | $1.0B | $24.9M | ||
| Q4 24 | $1.1B | $23.0M | ||
| Q3 24 | $1.1B | $22.3M | ||
| Q2 24 | $1.1B | $20.3M | ||
| Q1 24 | $1.1B | $19.6M |
| Q4 25 | $1.4B | $84.0M | ||
| Q3 25 | $1.4B | $51.2M | ||
| Q2 25 | $1.4B | $52.7M | ||
| Q1 25 | $1.3B | $47.1M | ||
| Q4 24 | $1.4B | $47.9M | ||
| Q3 24 | $1.4B | $43.0M | ||
| Q2 24 | $1.4B | $47.2M | ||
| Q1 24 | $1.5B | $45.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $3.9M |
| Free Cash FlowOCF − Capex | $-44.6M | $3.7M |
| FCF MarginFCF / Revenue | -99.4% | 7.8% |
| Capex IntensityCapex / Revenue | 21.9% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 7.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $6.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $3.9M | ||
| Q3 25 | $-52.6M | $-1.7M | ||
| Q2 25 | $-32.4M | $6.0M | ||
| Q1 25 | $-11.6M | $-857.0K | ||
| Q4 24 | $-108.6M | $4.8M | ||
| Q3 24 | $-28.9M | $-2.4M | ||
| Q2 24 | $-30.0M | $3.6M | ||
| Q1 24 | $-41.7M | $6.7M |
| Q4 25 | $-44.6M | $3.7M | ||
| Q3 25 | $-61.5M | $-2.2M | ||
| Q2 25 | $-45.8M | $5.5M | ||
| Q1 25 | $-22.2M | $-930.0K | ||
| Q4 24 | $-187.0M | $2.5M | ||
| Q3 24 | $-47.4M | $-4.0M | ||
| Q2 24 | $-50.1M | $2.5M | ||
| Q1 24 | $-65.8M | $6.6M |
| Q4 25 | -99.4% | 7.8% | ||
| Q3 25 | -687.0% | -6.2% | ||
| Q2 25 | -267.9% | 15.5% | ||
| Q1 25 | -524.0% | -2.8% | ||
| Q4 24 | -3702.8% | 8.0% | ||
| Q3 24 | -728.4% | -14.1% | ||
| Q2 24 | -683.8% | 8.4% | ||
| Q1 24 | -661.5% | 24.8% |
| Q4 25 | 21.9% | 0.4% | ||
| Q3 25 | 99.7% | 1.5% | ||
| Q2 25 | 78.2% | 1.5% | ||
| Q1 25 | 251.1% | 0.2% | ||
| Q4 24 | 1552.7% | 7.2% | ||
| Q3 24 | 284.6% | 5.6% | ||
| Q2 24 | 274.6% | 3.8% | ||
| Q1 24 | 242.5% | 0.4% |
| Q4 25 | — | 7.16× | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | 4.85× | ||
| Q1 25 | — | -0.54× | ||
| Q4 24 | — | 11.71× | ||
| Q3 24 | — | -2.10× | ||
| Q2 24 | — | 6.58× | ||
| Q1 24 | — | 4.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
